Advertisement
Advertisement

INGN

INGN logo

Inogen Inc

6.44
USD
Sponsored
-0.22
-3.30%
Apr 10, 13:03 UTC -4
Open

INGN Earnings Reports

Positive Surprise Ratio

INGN beat 31 of 41 last estimates.

76%

Next Report

Date of Next Report
Apr 30, 2026
Estimate for Q1 26 (Revenue/ EPS)
$84.00M
/
-$0.28
Implied change from Q4 25 (Revenue/ EPS)
+2.79%
/
+7.69%
Implied change from Q1 25 (Revenue/ EPS)
+2.09%
/
+12.00%

Inogen Inc earnings per share and revenue

On Feb 24, 2026, INGN reported earnings of -0.26 USD per share (EPS) for Q4 25, beating the estimate of -0.36 USD, resulting in a 28.69% surprise. Revenue reached 81.72 million, compared to an expected 86.75 million, with a -5.80% difference. The market reacted with a +0.16% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.28 USD, with revenue projected to reach 84.00 million USD, implying an increase of 7.69% EPS, and increase of 2.79% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
AngioDynamics, Inc.
Report Date
Apr 02, 2026 For Q3 26
Estimate
-$0.11
Actual
$0.02
Surprise
+117.83%
logo
LENSAR, Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.07
Actual
-$0.12
Surprise
-68.07%
logo
Xtant Medical Holdings, Inc.
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.00
Actual
$0.00
Surprise
+100.00%
logo
Adagio Medical Holdings, Inc Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$0.31
Actual
-$0.16
Surprise
+49.40%
logo
PAVmed Inc. Common Stock
Report Date
Mar 27, 2026 For Q4 25
Estimate
-$5.50
Actual
-$5.52
Surprise
-0.22%
logo
American Shared Hospital Services
Report Date
Mar 31, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.09
Surprise
-545.54%
logo
NexGel, Inc Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.12
Surprise
-30.72%
logo
ENDRA Life Sciences Inc. Common Stock
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$1.25
Actual
-$3.26
Surprise
-159.84%
FAQ
For Q4 2025, Inogen Inc reported EPS of -$0.26, beating estimates by 28.69%, and revenue of $81.72M, -5.8% below expectations.
The stock price moved up 0.16%, changed from $6.21 before the earnings release to $6.22 the day after.
The next earning report is scheduled for Apr 30, 2026.
Based on 4 analysts, Inogen Inc is expected to report EPS of -$0.28 and revenue of $84.00M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement